Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
about
Granuloma formation in pulmonary sarcoidosisChitotriosidase in the Pathogenesis of Inflammation, Interstitial Lung Diseases and COPDDown-regulation of immune responses in the lower respiratory tract: the role of alveolar macrophagesRelation between immunocytological features of bronchoalveolar lavage fluid and clinical indices in sarcoidosis.Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic proteinase. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity.Cigarette smoking decreases global microRNA expression in human alveolar macrophages.Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective responseGamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.The alveolar macrophages in asthma: a double-edged sword.Inflammation and pathological damage to the lungs of mice are only partially reversed following smoking cessation on subacute exposure to cigarette smoke.Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3.Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells.Clonal expansion of lung V delta 1+ T cells in pulmonary sarcoidosis.Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptorsPhenotypic analysis of alveolar macrophages in normal subjects and in patients with interstitial lung disease.Defective cell mediated immunity in sarcoidosis: effect of interleukin-2Expression of surface antigens distinguishing "naive" and previously activated lymphocytes in bronchoalveolar lavage fluidSpontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subsetThe Role of Interleukin-23 in the Early Development of Emphysema in HIV1(+) Smokers.Immune aspects of sarcoidosis.A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent TB Infection.Exhaled breath markers of alveolar macrophage activity in sarcoidosis.Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.HLA-DR antigens on human macrophages from bronchoalveolar lavage fluid.Expression of Ia by murine alveolar macrophages is upregulated during the evolution of a specific immune response in pulmonary parenchyma.Expression of HLA class II genes in alveolar macrophages of patients with sarcoidosis.Macrophage-derived biomarkers of idiopathic pulmonary fibrosis.Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.Normal human alveolar macrophages have more ability than blood monocytes to produce cell-associated interleukin-1-alpha.Hypothalamic digoxin, hemispheric chemical dominance, and sarcoidosis.Macrophages activated by fibrin increase albumin permeability across pulmonary artery endothelial monolayers.Hypothalamic digoxin, hemispheric chemical dominance and sarcoidosis.Regulation of major histocompatibility complex class II antigens on human alveolar macrophages by granulocyte-macrophage colony-stimulating factor in the presence of glucocorticoidsSpectrum of Immunoregulatory Functions and Properties of Human Alveolar Macrophages
P2860
Q26863703-CD61684F-1EE1-408E-A0F5-AFE972EF0941Q28384802-2D5B4D7A-F176-4374-A351-90A32DA5874BQ28391271-4335F4E4-5D88-4257-9EBF-DEE1B4C2DBA0Q33604078-9B1D12F3-9441-4D47-BA11-F6E84368AC5AQ33848563-00B61687-FD43-454C-B6F4-2D21E44CEA3DQ34406179-08642834-911D-4281-995C-A096674F3EEEQ34432488-86809A70-8DE8-45F0-9E45-9EB5EA6F94C5Q34627050-04FBC29F-196B-46FB-8544-5AA80EF70C3AQ34641655-B986199A-0611-4BCE-86CA-6C15FDCE0DE2Q35387858-C3E870F1-8B70-4A49-82B3-5BDC147B062BQ35576906-55D5B594-321B-4619-8EBC-4BD34CA1A5A1Q35818454-0709309B-C4C4-4542-B1DC-B76CBC7D0760Q35824080-B585111D-2CA6-434D-8A98-97DEC300B636Q35835801-730435F6-2822-4BF4-B72B-AC42DC55156EQ36155661-D3C7F88B-3229-41E3-924C-D3371628DC42Q36192825-6741FDB5-3C6E-4D0F-8E45-4375C4BDCCC5Q36220957-BCFA8F4C-9AB0-4E6C-A639-D948E88DE3C7Q36994696-241D268C-C77E-456B-A1CF-85A776AB8B69Q37089260-845947E9-F324-4B10-A459-B0A42CEE5CFCQ39185566-6749F901-8410-46BD-8DA4-38405FBCBC53Q40179059-422B2926-CAA0-4983-BB86-CB67368296A5Q40743944-C8AF67D5-DA9A-4D4F-BAA9-BE3A57422118Q40971242-128C2FE7-E07E-4DE8-B186-B48C6E602026Q40976985-12566FA2-64BD-40F5-BC2F-7ABE9412537CQ41125035-F97B53B0-5860-4713-8BAA-28CEEE4B2293Q41254839-BC032F85-CD6E-4C73-A9DA-5CA8EB1CE269Q41266349-2267AD10-519B-4400-90D2-F2CC3A4F3DC5Q42099223-660DE7C2-29CA-4EEA-8CAE-8CF9233FFB8BQ43204395-31A16C04-71C7-4DD7-8B94-80109507C795Q43458007-2BB479B4-CD9C-46CD-9B0F-562F998DD6BAQ44636831-61E205D9-ECD3-4AA4-AD5D-093F5897AA27Q45137619-DA84FA82-1B3B-4A1E-9775-30AF4766E1FDQ47416709-0C3CB042-D0E5-4DA2-8A11-7612D91A0E03Q57384900-83DBAF46-2381-4717-8D72-3D95BA21FAB6Q58329579-5ACACE5D-4F58-4D31-A56D-2365EB9771D7
P2860
Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis.
description
1985 nî lūn-bûn
@nan
1985 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@ast
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@en
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@nl
type
label
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@ast
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@en
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@nl
prefLabel
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@ast
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@en
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@nl
P2093
P2860
P356
P1476
Enhanced alveolar macrophage-m ...... proliferation in sarcoidosis.
@en
P2093
P2860
P304
P356
10.1172/JCI111688
P407
P577
1985-01-01T00:00:00Z